Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease

被引:0
|
作者
Richard Abraham
Amanda Myers
Fabienne Wavrant-DeVrieze
Marian L. Hamshere
Hollie V. Thomas
Helen Marshall
Danielle Compton
Gillian Spurlock
Dragana Turic
Bastiaan Hoogendoorn
Jennifer M. Kwon
Ronald C. Petersen
Eric Tangalos
Joanne Norton
John C. Morris
Roger Bullock
Danae Liolitsa
Simon Lovestone
John Hardy
Alison Goate
Michael O'Donovan
Julie Williams
Michael J. Owen
Lesley Jones
机构
[1] Department of Psychological Medicine,
[2] University of Wales College of Medicine,undefined
[3] Cardiff CF14 4XN,undefined
[4] UK,undefined
[5] Institute of Medical Genetics,undefined
[6] University of Wales College of Medicine,undefined
[7] Cardiff CF14 4XN,undefined
[8] UK,undefined
[9] Departments of Psychiatry and Neurology,undefined
[10] Washington University School of Medicine,undefined
[11] 660 S Euclid,undefined
[12] St. Louis,undefined
[13] MO 63110,undefined
[14] USA,undefined
[15] Laboratory for Neurogenetics,undefined
[16] Birdsall Building,undefined
[17] Mayo Clinic Jacksonville,undefined
[18] Jacksonville FL 32224,undefined
[19] USA,undefined
[20] Departments of Neurology and General Medicine,undefined
[21] Mayo Clinic,undefined
[22] Rochester,undefined
[23] MN55905,undefined
[24] USA,undefined
[25] Department of Old Age Psychiatry,undefined
[26] Victoria Hospital,undefined
[27] Okus Road,undefined
[28] Swindon SN1 4JU,undefined
[29] UK,undefined
[30] Institute of Psychiatry,undefined
[31] De Crespigny Park,undefined
[32] Denmark Hill,undefined
[33] London SE5 8AF,undefined
[34] UK,undefined
来源
Human Genetics | 2001年 / 109卷
关键词
Marker D10S583; Summary Odds Ratio; Minor Haplotype; Bacterial Artificial Chromo; Genotyping Restriction Fragment Length Polymorphism;
D O I
暂无
中图分类号
学科分类号
摘要
Insulin-degrading enzyme (IDE; insulysin; EC 3.4.24.56) is a 110-kDa neutral metallopeptidase that can degrade a number of peptides including β-amyloid. The gene encoding IDE is located on chromosome 10 close to a region of linkage for late-onset Alzheimer's disease (LOAD) and thus is a functional and positional candidate for this disorder. We analysed all of the coding exons, untranslated regions and 1000 bp of 5′-flanking sequence of IDE by using denaturing high-performance liquid chromatography and sequencing. We detected eight single nucleotide polymorphisms (SNPs), three in the 5′ flanking sequence and five in the coding sequence, of which three were found at lower than 5% frequency. None of them changed the amino acid sequence. We genotyped the five SNPs with allele frequencies of more than 5% in 133 Caucasian LOAD cases and 135 controls collected in the UK and 95 cases and 117 controls collected at the Mayo Clinic, Rochester, USA. Two of the SNPs were analysed in a further independent case-control sample (Washington University, St. Louis: 86 cases, 94 controls). No significant association was found with any individual SNP in any of the samples or with any haplotypes. Analysis of the marker D10S583, which maps 36 kb upstream of IDE, also failed to show association in 134 cases and 111 matched controls from the UK (P=0.63). Strong linkage disequilibrium was detected between the five SNPs that spanned the whole of the 120-kb genomic region of IDE and one major and a number of minor haplotypes were detected in the populations studied. We conclude that IDE does not make a substantial contribution to the aetiology of LOAD and therefore cannot account for the linkage between LOAD and 10q.
引用
收藏
页码:646 / 652
页数:6
相关论文
共 50 条
  • [1] Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease
    Abraham, R
    Myers, A
    Wavrant-DeVrieze, F
    Hamshere, ML
    Thomas, HV
    Marshall, H
    Compton, D
    Spurlock, G
    Turic, D
    Hoogendoorn, B
    Kwon, KM
    Petersen, RC
    Tangalos, E
    Norton, J
    Morris, JC
    Bullock, R
    Liolitsa, S
    Lovestone, S
    Hardy, J
    Goate, A
    O'Donovan, M
    Williams, J
    Owen, MJ
    Jones, L
    HUMAN GENETICS, 2001, 109 (06) : 646 - 652
  • [2] Substantial linkage disequilibrium the insulin degrading enzyme locus but no association with late-onset Alzheimer's disease
    Jones, L
    Abraham, R
    Myers, A
    DeVrieze, FW
    Hamshere, MV
    Thomas, HM
    Marshall, H
    Compton, D
    Spurlock, G
    Turic, D
    Hoogendorn, B
    Kwon, JM
    Petersen, RC
    Tanaglos, E
    Norton, J
    Morris, JC
    Bullock, R
    Liolitsa, D
    Lovestone, S
    Hardy, J
    Goate, A
    O'Donovan, M
    Williams, J
    Owen, MJ
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 105 (07): : 627 - 628
  • [3] Association Between Polymorphisms of the Insulin-Degrading Enzyme Gene and Late-Onset Alzheimer Disease
    Wang, Shitao
    He, Feiyan
    Wang, Ying
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2015, 28 (02) : 94 - 98
  • [4] Lack of association of 5 SNPs in the vicinity of the insulin-degrading enzyme (IDE) gene with late-onset Alzheimer's disease
    Ozturk, Ayla
    DeKosky, Steven T.
    Kamboh, M. Ilyas
    NEUROSCIENCE LETTERS, 2006, 406 (03) : 265 - 269
  • [5] Is variation in the gene encoding insulin-degrading enzyme (IDE) a risk factor in late-onset Alzheimer's disease?
    Nowotny, P
    Smemo, S
    Hinrichs, T
    Holmans, P
    Tracey, K
    Doil, L
    Grupe, A
    Goate, A
    NEUROBIOLOGY OF AGING, 2004, 25 : S496 - S497
  • [6] Polymorphism Rs2421943 of the Insulin-Degrading Enzyme Gene and the Risk of Late-Onset Alzheimer's Disease
    Sery, Omar
    Zeman, Tomas
    Halova, Alice
    Janout, Vladimir
    Janoutova, Jana
    Lochman, Jan
    Balcar, Vladimir J.
    CURRENT ALZHEIMER RESEARCH, 2022, 19 (03) : 236 - 245
  • [7] Insulin degrading enzyme is not associated with late-onset Alzheimer's disease.
    Abraham, R
    Hamshere, M
    Myers, A
    Kwon, J
    Spurlock, G
    Thomas, H
    Turic, D
    Marshall, H
    De-Vrieze, FW
    Compton, D
    Hoogendoom, B
    Liolitsa, D
    Lovestone, S
    Hardy, J
    Goate, A
    O'Donovan, M
    Williams, J
    Owen, MJ
    Jones, L
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 562 - 562
  • [8] Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme
    Nowotny, P
    Hinrichs, AL
    Smemo, S
    Kauwe, JSK
    Maxwell, T
    Holmans, P
    Hamshere, M
    Turic, D
    Jehu, L
    Hollingworth, P
    Moore, P
    Bryden, L
    Myers, A
    Doil, LM
    Tacey, KM
    Gibson, AM
    McKeith, IG
    Perry, RH
    Morris, CM
    Thal, L
    Morris, JC
    O'Donovan, MC
    Lovestone, S
    Grupe, A
    Hardy, J
    Owen, MJ
    Williams, J
    Goate, A
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 136B (01) : 62 - 68
  • [9] Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-ε4 allele
    Cook, DG
    Leverenz, JB
    McMillan, PJ
    Kulstad, JJ
    Ericksen, S
    Roth, RA
    Schellenberg, GD
    Jin, LW
    Kovacina, KS
    Craft, S
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (01): : 313 - 319
  • [10] Insulin-degrading enzyme, apolipoprotein E, and Alzheimer’s disease
    Steven D. Edland
    Journal of Molecular Neuroscience, 2004, 23 : 213 - 217